Regorafénib N-oxyde (M2)
Regorafenib N-oxide M2 is the active metabolite of Regorafenib, a multi-kinase inhibitor targeting VEGFR, PDGFRβ, RET, Kit, and Raf-1. This compound is utilized in cancer research, particularly for studying drug metabolism and efficacy in both in vitro biochemical assays and in vivo tumor models.
Product Specifications
CAS Number
835621-11-9
Product Name Alternative
CKit, cRET, Drug Metabolite, DrugMetabolite, Inhibitor, Kit, inhibit, Platelet-derived growth factor receptor, PDGFR, VEGFR2, VEGFR1, VEGFR3, Regorafénib N-oxyde, Regorafénib Noxyde (M2), Regorafénib N-oxyde (M2), Regorafénib N-oxyde (M-2), Regorafénib N oxyde (M2), PDGFRβ, Raf-1, RET
Field of Research
Cardiovascular Research, Cell Biology, Metabolism Research, Signal Transduction
Purity
95.26% (May vary between batches)
Solubility
DMSO:5.67 mg/mL (11.37 mM)
Smiles
CNC (=O) c1cc (Oc2ccc (NC (=O) Nc3ccc (Cl) c (c3) C (F) (F) F) c (F) c2) cc[n+]1[O-]
Molecular Formula
C21H15ClF4N4O4
Molecular Weight
498.81
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
